Cardiac function and antiepileptic drug treatment in the elderly: A comparison between lamotrigine and sustained-release carbamazepine

Epilepsia

Volumn 50, Issue 8, 2009, Pages 1841-1849

  Saetre, Erik ^a   Abdelnoor, Mikael ^a   Amlie, Jan Peder ^c   Tossebro, Morten ^b   Perucca, Emilio ^b,d   Taubøll, Erik ^b,c   Anfinsen, Ole Gunnar ^b   Isojärvi, Jouko ^e,f   Gjerstad, Leif ^b,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF OULU   (Finland)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Carbamazepine; Cardiac function; ECG; Elderly; Epilepsy; Heart; Lamotrigine

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARBAMAZEPINE; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAMOTRIGINE; NITRIC ACID DERIVATIVE; THIAZIDE DIURETIC AGENT; WARFARIN;

AGED; ANGINA PECTORIS; ARTICLE; ASTHENIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EPILEPSY; FEMALE; HEART FUNCTION; HEART PALPITATION; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PNEUMONIA; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SKIN MANIFESTATION; SOMNOLENCE; STROKE; SUSTAINED DRUG RELEASE; SYNCOPE; TACHYCARDIA; THORAX PAIN; UNSPECIFIED SIDE EFFECT;

EID: 68149107602     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02069.x     Document Type: Article

References (51)

1. Abdelnoor M, Nitter-Hauge S, Risum Ø, Svennevig JL, Amlie JP 2000) Duration of preoperative electrocardiographic QRS complex and the incidence of heart arrest after aorto coronary bypass surgery. Scand Cardiovasc J 34 : 186 191.
2. Aurlien D, Taubøll E, Gjerstad L 2007) Lamotrigine in idiopathic epilepsy - increased risk of cardiac death? Acta Neurol Scand 115 : 199 203.
3. Beermann B, Edhag O, Vallin H 1975) Advanced heart block aggravated by carbamazepine. Br Heart J 37 : 668 671.
4. Beermann B, Edhag O 1978) Depressive effects of carbamazepine on idioventricular rhythm in man. Br Med J. 15 2 (6131 171 172.
5. Benassi E, Bo GP, Cocito L, Maffini M, Loeb C 1987) Carbamazepine and cardiac conduction disturbances. Ann Neurol 22 (2 280 281.
6. Boesen F, Andersen EB, Jensen EK, Ladefoged SD 1983) Cardiac conduction disturbances during carbamazepine therapy. Acta Neurol Scand 68 : 49 52.
7. Brodie MJ, Overstall PW, Giorgi L 1999) Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 37 : 81 87.
8. Buckley NA, Whyte IM, Dawson AH 1993) Self-poisoning with lamotrigine (letter). Lancet 342 : 1552 1553.
9. Byrne E, Wong CH, Chambers DG, Rice JP 1979) Carbamazepine therapy complicated by nodal bradycardia and water intoxication. Aust N Z Med 9 (3 295 296.
10. Checchini M, Magni M, Scaglione M, Vaccarella A 1995) Cardiac effects of carbamazepine therapy. Minerva Cardioangiol 43 : 379 381.
11. Danielsson BR, Lansdell K, Patmore L, Tomson T 2005) Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents. Epilepsy Res 63 : 17 25.
12. Desai AD, Yaw TS, Yamazaki T, Kaykha A, Chun S, Froelicher VF 2006) Prognostic significance of quantitative QRS duration. Am J Med 119 : 600 606.
13. Dollery C (Ed 1999) Therapeutic drug. CD release 1.0, Churchill Livingstone, Oxford, UK.
14. Elhendy A, Hammill SC, Mahoney DW, Pellikka PA 2005) Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol 96 : 1082 1088.
15. Hamilton DV 1978) Carbamazepine and heart block. Lancet 24; 1(8078) : 1365.
16. Herold TJS 2006) Lamotrigine as a possible cause of QRS prolongation in a patient with known seizure disorder. CJEMS 8 : 361 364.
17. Herzberg L 1978) Carbamazepine and bradycardia. Lancet 20 1 (8073 1097 1098.
18. Hevetson KA, Ritch AE, Watson RD 1986) Sick sinus syndrome aggravated by carbamazepine therapy for epilepsy. Postgrad Med J. 62 (728 497 498.
19. Hitiris N, Suratman S, Kelly K, Stephen LJ, Sills GJ, Brodie MJ 2007) Sudden unexpected death in epilepsy: a search for risk factors. Epilepsy Behav 10 : 138 141.
20. Hojer J, Malmlund HO, Berg A 1993) Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine. J Toxicol Clin Toxicol. 31 (3 449 458.
21. Ide A, Kamijo Y 2007) Intermittent complete atrioventricular block after long term low-dose carbamazepine therapy with a serum concentration less than the therapeutic level. Intern Med 46 : 627 629.
22. Johnson CD, Rivera H, Jiménez JE 1997) Carbamazepine-induced sinus node dysfunction. P R Health Sci J 16 : 45 49.
23. Kalahasti V, Nambi V, Martin DO, Lam CT, Yamada D, Wilkoff BL, Niebauer MJ, Jaeger FJ, Tchou PJ, Chung MK 2003) QRS duration and the prediction of mortality in patients undergoing risk stratification for ventricular arrhythmias. Am J Cardiol 92 (7 798 803.
24. Kasarskis EJ, Kuo CS, Berger R, Nelson KR 1992) Carbamazepine-induced cardiac dysfunction. Characterization of two distinct clinical syndromes. Arch Intern Med 152 : 186 191.
25. Kaul S, Meena AK, Murthy JM 2000) Carbamazepine induced bradycardia. Neurol India 48 : 403 404.
26. Kennebäck G, Bergfeldt L, Vallin H, Tomson T, Edhag O 1991) Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system. Am Heart J 121 : 1421 1429.
27. Kennebäck G, Bergfeldt L, Tomson T, Spina E, Edhag O 1992) Carbamazepine induced bradycardia - a problem in general or only in susceptible patients? A 24-h long-term electrocardiogram study. Epilepsy Res 13 : 141 145.
28. Knilans TK 1994) Carbamazepine-induced atrioventricular block in a child with tuberous sclerosis and cardiac rhabdomyoma. Ann Neurol 36 : 804 805.
29. Kumada T, Hattori H, Doi H, Shiraishi K, Yamanaka Y, Kato T, Nakahata T 2005) Postoperative complete atrioventricular block induced by carbamazepine in a patient with congenital heart disease. No To Hattatsu 37 : 257 261.
30. Labrecque J, Cote MA, Vincent P 1992) Carbamazepine-induced atrioventricular block. Am J Psychol 149 : 572 573.
31. Ladefoged SD, Møgelvang JC 1982) Total atrioventricular block with syncopes complicating carbamazepine therapy. Acta Med Scand 212 : 185 186.
32. MacNab AZ, Robinson JL, Adderly RZ, D'Orsogna L 1978) Heart block secondary to erythromycin induced carbamazepine therapy. Pediatrics 80 : 951 952.
33. Matteoli S, Trappolini M, Curione M, Fanari F, Borgia MC, Puletti M 1994) Effects of carbamazepine on heart conduction in young patients: a serial study using ambulatory ECG. G Ital Cardiol 24 : 391 397.
34. Moher D, Schulz KF, Altmann DG 2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 : 1191 1194. (Pubitemid 32378696)
35. Nilsson L, Bergman U, Diwan V, Farahmand BY, Persson PG, Tomson T 2001) Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study. Epilepsia 42 : 667 673.
36. Opeskin K, Burke MP, Cordner SM, Berkovic SF 1990) Comparison of antiepileptic drug levels in sudden unexpected deaths in epilepsy with deaths from other causes. Epilepsia 40 : 1795 1798.
37. Persson H, Ericson M, Tomson T 2003) Carbamazepine affects autonomic cardiac control in patients with newly diagnosed epilepsy. Epilepsy Res 57 : 69 75.
38. Persson H, Kumlien E, Ericson M, Tomson T 2007) Circadian variation in heart-rate variability in localization-related epilepsy. Epilepsia 48 : 917 922.
39. Perucca E 2006) Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol 61 : 246 255.
40. Pocock SJ 1990) Clinical trials. A practical approach. John Wiley & Sons, London, UK.
41. Pudil R, Feinberg MS, Hod H, Boyko V, Mandelzweig L, Behar S 2001) The prognostic significance of intermediate QRS prolongation in acute myocardial infarction. Int J Cardiol 78 : 233 239.
42. Puletti M, Iani C, Curione M, Trappolini M, Manfredi M 1991) Carbamazepine and the heart. Ann Neurol 29 : 575 576.
43. Rogawski MA, Löscher W 2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5 : 553 564.
44. Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, Spitz M, Frederick T, Towne A, Carter GS, Marks W, Felicetta J, Tomyanovich ML, VA Cooperative Study 428 Group 2005) New onset geriatric epilepsy: a randomised study of gabapentin, lamotrigine, and carbamazepine. Neurology 64 : 1868 1873.
45. Saetre E, Perucca E, Isojärvi J, Gjerstad L, on behalf of the LAM 40089 study group 2007) An international multicenter randomised double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 48 : 1292 1302.
46. Steinhoff BJ, Stodieck SR, Tiecks FP, Wedel R, Polatschek B 1994) Cardiac side effects and ECG changes with lamotrigine? - A clinical study. Schweiz Arch Neurol Psychiatr 145 : 8 12.
47. Takayanagi K, Hisauchi I, Watanabe J, Maekawa Y, Fujito T, Sakai Y, Hoshi K, Kase M, Nishimura N, Inoue T, Hayashi T, Morooka S 1998) Carbamazepine-induced sinus node dysfunction and atrioventricular block in elderly women. Jpn Heart J 39 : 469 479.
48. Timmings PL 1998) Sudden unexpected death in epilepsy: is carbamazepine implicated? Seizure 7 : 289 291.
49. Van Landingham KE, Dixon RM 2007) Lamotrigine in idiopathic epilepsy - increased risk of cardiac death (letter to the editor). Acta Neurol Scand 116 : 345.
50. Weig SG, Pollack P 1993) Carbamazepine-induced heart block in a child with tuberous sclerosis and cardiac rhabdomyoma: implications for evaluation and follow-up. Ann Neurol 34 : 617 619.
51. Yerra L, Anavekar N, Skali H, Zelenkofske S, Velazquez E, McMurray J, Pfeffer M, Solomon SD 2006) Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. Heart Rhythm 3 : 313 316.